Searchable abstracts of presentations at key conferences in endocrinology

ea0016p147 | Clinical cases | ECE2008

Severe nonalcoholic fatty liver disease in a young woman with polycystic ovary syndrome and insulin resistance: case report

Leustean Letitia , Preda Cristina , Vulpoi Carmen , Ungureanu Maria-Christina , Cristea Cristina , Cijevschi Cristina , Nemescu Dragos , Zbranca Eusebie

Women with polycystic ovary syndrome (PCOS) and insulin resistance have an increased risk of developing many of the consequences of the metabolic syndrome. Obesity, but in particular metabolic syndrome seems to be the main cause of nonalcoholic fatty liver disease (NAFLD) so, it is not surprising that NAFLD is very common in patients with PCOS. We present the case of a 23-year-old woman diagnosed with PCOS and insulin resistance in our Endocrinology Clinic (irregular menses, h...

ea0014p372 | (1) | ECE2007

Predictive factors for thyroid function abnormalities in patients with chronic hepatitis C treated with pegylated interferon and ribavirin

Cijevschi Cristina , Mihai Catalina , Zbranca Eusebie , Gogalniceanu Paul

Introduction: Chronic hepatitis C has a high incidence in our country being a major public health issue.Aims and methods: To establish prognostic factors for developing thyroid dysfunction in patients with chronic hepatitis C receiving pegylated interferon and ribavirin therapy. A prospective study of patients with chronic hepatitis C on antiviral therapy was undertaken. 68 patients started on antiviral therapy in the period 1st January 2003 – 1st J...

ea0014p373 | (1) | ECE2007

Aetiology and therapeutic guideines in thyrid dysfunction at the patients with chronic hepatitis C treated with pegylated interferon and ribavirin

Cijevschi Cristina , Mihai Catalina , Zbranca Eusebie , Brumaru Andreea , Gogalniceanu Paul

Introduction: Chronic Hepatitis C is highly prevalent in our country.Management involves combination treatment with pegylated interferon and ribavirin. Thyroid disease in affected patients can be caused by the hepatitis C virus or by the interferon therapy.Aims and method: The study aims to investigate thyroid dysfunction and optimal management strategies for patients with chronic hepatitis C treated with pegylated interferon and r...